Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Vasogen to extend clinical trials with VasoCare

Feb. 20, 1997

Subtype-selective 5-HT1 antagonists from Pierre Fabre

Feb. 20, 1997

Astra anesthetic/analgesic introduced in the U.K.

Feb. 19, 1997

GRC-active agents from CoCensys modulate brain excitability

Feb. 19, 1997

Gliatech prepares H3 agonists

Feb. 19, 1997

Antidepressant with minimal impact on sexual function introduced

Feb. 18, 1997

TCR peptides for MS reported by Connective Therapeutics

Feb. 18, 1997

Yeda discloses peptides for myasthenia gravis

Feb. 18, 1997

Abbott discloses nicotinic cholinergic channel modulators

Feb. 18, 1997

Adenosine kinase inhibitors prepared by Gensia

Feb. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...